Niels Haan

Niels Haan

Auto-generated profile, based on publicly available information

Niels Haan

Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NHNiels Haan
Niels Haan
TGTimothy Goodman
Timothy Goodman
ANAlaleh Najdi-Samiei
Alaleh Najdi-Samiei
CSChristina M. Stratford
Christina M. Stratford
RRRitva Rice
Ritva Rice
MHMohammad K. Hajihosseini
Mohammad K. Hajihosseini
Increasing evidence suggests that neurogenesis occurs in the postnatal and adult mammalian hypothalamus. However, the identity and location of the putative progenitor cells is under much debate, and little is known about the dynamics of neurogenesis in unchallenged brain. Previously, we postulated that Fibroblast growth factor 10-expressing (Fgf10+) tanycytes constitute a population of progenitor cells in the mouse hypothalamus. Here, we show that Fgf10+tanycytes express markers of neural stem/progenitor cells, divide late into postnatal life, and can generate both neurons and astrocytesin vivo. Stage-specific lineage-tracing of Fgf10+tanycytes using Fgf10-creERT2 mice, reveals robust neurogenesis at postnatal day 28 (P28), lasting as late as P60. Furthermore, we present evidence for amplification of Fgf10-lineage traced neural cells within the hypothalamic parenchyma itself. The neuronal descendants of Fgf10+tanycytes predominantly populate the arcuate nucleus, a subset of which express the orexigenic neuronal marker, Neuropeptide-Y, and respond to fasting and leptin-induced signaling. These studies provide direct evidence in support of hypothalamic neurogenesis during late postnatal and adult life, and identify Fgf10+tanycytes as a source of parenchymal neurons with putative roles in appetite and energy balance.

4 July 2018 in Schizophrenia Bulletin
Verified
Journal Article
Closed access
AMAnna L Moon
Anna L Moon
NHNiels Haan
Niels Haan
LWLawrence S Wilkinson
Lawrence S Wilkinson
KTKerrie L Thomas
Kerrie L Thomas
JHJeremy Hall
Jeremy Hall
Large-scale genome-wide association studies have consistently shown that genetic variation in CACNA1C, a gene that encodes calcium voltage-gated channel subunit alpha1C, increases risk for psychiatric disorders. CACNA1C encodes the Cav1.2 subunit of voltage-gated calcium channels, which themselves have been functionally implicated in a broad spectrum of neuropsychiatric syndromes. Research has concentrated on uncovering the underlying biological mechanisms that could be responsible for this increased risk. This review presents an overview of recent findings regarding Cacna1c variation in animal models, particularly focusing on behavioral phenotypes associated with neurodevelopmental disorders such as cognition, anxiety and depressive phenotypes, and fear conditioning. The impact of reduced gene dosage of Cacna1c on adult hippocampal neurogenesis is also assessed, including new data from a novel Cacna1c+/- rat model.

1 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Ana SilvaAna Silva
Ana Silva
JHJosephine E. Haddon
Josephine E. Haddon
YSYasir Ahmed Syed
Yasir Ahmed Syed
STSimon Trent
Simon Trent
TLTzu-Ching E. Lin
Tzu-Ching E. Lin
LWLawrence WILKINSON
Lawrence WILKINSON
The biological basis of the increased risk for psychiatric disorders seen in 15q11.2 copy number deletion is unknown. Previous work has shown disturbances in white matter tracts in human carriers of the deletion. Here, in a novel rat model, we recapitulated low dosage of the candidate risk geneCYFIP1present within the 15q11.2 interval. Using diffusion tensor imaging, we first showed extensive white matter changes inCyfip1mutant rats, which were most pronounced in the corpus callosum and external capsule. Transmission electron microscopy showed that these changes were associated with thinning of the myelin sheath in the corpus callosum. Myelin thinning was independent of changes in axon number or diameter but was associated with effects on mature oligodendrocytes, including aberrant intracellular distribution of myelin basic protein. Finally, we demonstrated effects on cognitive phenotypes sensitive to both disruptions in myelin and callosal circuitry.

30 May 2015 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
NHNiels Haan
Niels Haan
BZBangfu Zhu
Bangfu Zhu
JWJian Wang
Jian Wang
XWXiao-Qing Wei
Xiao-Qing Wei
BSBing Song
Bing Song
Large-scale macrophage infiltration and reactive astrogliosis are hallmarks of early spinal cord injury (SCI) pathology. The exact nature of the macrophage response and relationship between these phenomena have not been explored in detail. Here, we have investigated these responses using a combination of in vivo SCI models, organotypic and primary cultures. In vivo macrophage response was investigated using a contusive injury mouse model. Interactions between astrocytes and macrophages were studied in primary or organotypic cultures. Proliferation was assessed though MTT assay and nucleotide incorporation and gene expression changes through qPCR. Seven days following contusive SCI, a mixed M1/M2 macrophage response was seen in the injury site. Conditioned medium from primary M1, but not M2, macrophages are able to induce astrocyte proliferation in both organotypic spinal cord cultures and primary astrocytes. Soluble factors from M1 macrophages induce a reactive astrocyte gene expression pattern, whereas M2 factors inhibit expression of these genes. M2-stimulated astrocytes are also able to decrease both M1 and M2 macrophage proliferation and decrease TNFα production in M1 macrophages. These results suggest a strong role of M1 macrophages in inducing reactive astrogliosis and the existence of an astrocyte-mediated negative feedback system in order to dampen the immune response. These results, combined with the poor outcomes of the current immunosuppressive steroid treatments in SCI, indicate the need for more targeted therapies, taking into account the significantly different effects of M1 and M2 macrophages, in order to optimise outcome.

1 February 2014 in Advances in Wound Care
Verified
Journal Article
Closed access
NHNiels Haan
Niels Haan
BSBing Song
Bing Song
Significance: Nervous system injuries, both in the peripheral nervous system (PNS) and central nervous system are a major cause for pain, loss-of-function, and impairment of daily life. As nervous system injuries commonly heal slowly or incompletely, new therapeutic approaches may be required. Recent Advances: The observation that cultured neurons are able to respond to exogenous electric fields (EFs) by sprouting more neurites and directing growth along the field, along with the presence of endogenous EFs in the developing vertebrate nervous system have led to the suggestion of the use of EFs in a regenerative therapeutic setting. This review discusses the effects of EFs on nervous cells, and their use in the treatment of nervous injuries in the eye, limb nerves, and the spinal cord. Exogenous EFs have been shown to be neuroprotective in various injury models of the eye, including traumatic injury, congenital degenerative retinopathy, and glaucoma. In the PNS, EFs are able to stimulate regrowth and functional recovery in damaged limb nerves. In the spinal cord, axonal regeneration and improved quality of life may be achieved using EF stimulation. Critical Issues: The optimal paradigm for electrical stimulation has not been determined, and the mechanisms behind the effect of EF are still largely unknown. Future Directions: Although the therapeutic use of EFs in the nervous system is still in its infancy, it is a promising therapeutic avenue for otherwise hard to treat injuries. The cellular/molecular mechanisms of such regulation need to be fully investigated, and the efficiency of applied EFs during wound healing needs to be optimized in a systematic approach in both animal models and future clinical trials.

1 January 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
LWLaura J. Westacott
Laura J. Westacott
THTrevor Humby
Trevor Humby
NHNiels Haan
Niels Haan
SBSophie A. Brain
Sophie A. Brain
EBEmma-Louise Bush
Emma-Louise Bush
LWLawrence WILKINSON
Lawrence WILKINSON